Post-Traumatic Stress Disorder (PTSD) - Market Insight, Epidemiology and Market Forecast - 2027

Publisher Name :
Date: 31-Jan-2018
No. of pages: 100
Delivery of the Report will take 2-3 working days once order is placed.

DelveInsight's "Post-Traumatic Stress Disorder (PTSD) - Market Insight, Epidemiology and Market Forecast - 2027" report provides a detailed analysis of the Post-Traumatic Stress Disorder (PTSD) epidemiology and market outlook for the 7MM.

Markets Covered

- United States

- EU5 (Germany, France, Italy, Spain, and the United Kingdom)

- Japan

Study Period: 2016-2027

Post-Traumatic Stress Disorder (PTSD) Understanding and Treatment Algorithm

The market report provides the overview of the Post-Traumatic Stress Disorder (PTSD) by providing the disease overview, definition, classification, symptoms, etiology, pathophysiology and diagnostic methods. It also covers the detailed treatment approaches and therapy areas under research and development for 7MM.

Post-Traumatic Stress Disorder (PTSD) Epidemiology

The report provides a comprehensive account of the total patient pool, diagnosed cases and potential patient pool eligible for the treatment. It also includes the explanation of changing trends of epidemiology after evaluating numerous studies, survey reports and views of key opinion leaders. The Report provides the 10 years forecast from 2018 to 2027 segmented by seven major markets, enabling to understand the potential of the Post-Traumatic Stress Disorder (PTSD) in the respective markets. The epidemiology data is presented with graphs and tables to provide a clear assessment of the landscape.

Post-Traumatic Stress Disorder (PTSD) Product Profiles & Analysis

The drug chapter segment covers the complete analysis of marketed drugs and Phase III & late Phase II pipeline drugs. This division focuses on the recent breakthroughs like clinical development analysis, agreements and collaborations, clinical trial details, allotted designations, published results, pharmacological effects, patent expiry, and expected launch timings. Moreover, advantages and disadvantages of the therapy along with opinion of experts for marketed and emerging drugs are also provided.

Post-Traumatic Stress Disorder (PTSD) Market Outlook

The report's market outlook delivers an understanding of the country-specific revenue and share by analyzing the performance of the current therapies and potential uptake of new products. The in-depth analysis helps to recognize the growing demand of the market by evaluating the annual cost of therapy, compliance rate, competition with other therapies, covered patient segment, impact of emerging technology in the forecast period. The views from the key opinion leaders adds more value to the analysis. This segment provides the relevant graphs and tables to have an effective outline of the Post-Traumatic Stress Disorder (PTSD) market.

Post-Traumatic Stress Disorder (PTSD) Market Share by Therapies

This division provides an understanding of the rate of drug uptake, drugs including both recently launched and those which show potential to get launched during the forecast period from 2016-2027. The analysis is based on patient uptake by therapies, sales projection of each drug by studying the reasons behind the maximal use of new drugs. A comparative analysis is also done on the basis of market share and size by assessing the drugs uptake to project the drug positioning in the market.

Post-Traumatic Stress Disorder (PTSD) Report Insights

- Patient Population in Post-Traumatic Stress Disorder (PTSD)

- Therapeutic Approaches in Post-Traumatic Stress Disorder (PTSD)

- Post-Traumatic Stress Disorder (PTSD) Pipeline Analysis

- Post-Traumatic Stress Disorder (PTSD) Market Size and Trends

- Post-Traumatic Stress Disorder (PTSD) Market Opportunities

- Impact of upcoming Therapies in Post-Traumatic Stress Disorder (PTSD)

Post-Traumatic Stress Disorder (PTSD) Report Key Strengths

- 10 Year Forecast

- 7MM Coverage

- Epidemiology Segmentation

- Drugs Uptake

- Highly Analyzed Market

- Key Cross Competition

Post-Traumatic Stress Disorder (PTSD) Report Assessment

- Current Treatment Practices in Post-Traumatic Stress Disorder (PTSD)

- Unmet Needs in Post-Traumatic Stress Disorder (PTSD)

- Market Attractiveness

- Market Drivers and Barriers

Key Benefits

- The report will help to develop Business Strategies by understanding the trends shaping and driving the Post-Traumatic Stress Disorder (PTSD) market

- Organize sales and marketing efforts by identifying the best opportunities for Post-Traumatic Stress Disorder (PTSD) market

- To understand the future market competition in the Post-Traumatic Stress Disorder (PTSD) market.

Post-Traumatic Stress Disorder (PTSD) - Market Insight, Epidemiology and Market Forecast - 2027

Table of Contents

1. Report Introduction
2. Post-Traumatic Stress Disorder (PTSD) Market Overview at a Glance
2.1. Market Share Distribution of Post-Traumatic Stress Disorder (PTSD) in 2017
2.2. Market Share Distribution of Post-Traumatic Stress Disorder (PTSD) in 2027
3. Disease Background and Overview: Post-Traumatic Stress Disorder (PTSD)
3.1. Introduction
3.2. Symptoms
3.3. Etiology
3.4. Risk Factors
3.5. Pathophysiology
3.6. Diagnosis
3.7. Treatment
4. Epidemiology and Patient Population
4.1. Key Findings
4.2. Total Prevalent/ Incident Patient Population of Post-Traumatic Stress Disorder (PTSD) in 7MM
4.3. Total Prevalent Patient Population of Post-Traumatic Stress Disorder (PTSD) in 7MM - By Countries
5. Epidemiology of Post-Traumatic Stress Disorder (PTSD) by Countries
5.1. United States
5.1.1. Assumptions and Rationale
5.1.2. Prevalent/Incident Cases of the Post-Traumatic Stress Disorder (PTSD)
5.1.3. Sub-Type Specific cases of the Post-Traumatic Stress Disorder (PTSD) *
5.1.4. Sex- Specific Cases of the Post-Traumatic Stress Disorder (PTSD) *
5.1.5. Diagnosed Cases of the Post-Traumatic Stress Disorder (PTSD)
5.1.6. Treatable Cases of the Post-Traumatic Stress Disorder (PTSD)
5.2. EU5
5.3. Assumptions and Rationale
5.4. Germany
5.4.1. Assumptions and Rationale
5.4.2. Prevalent/Incident Cases of the Post-Traumatic Stress Disorder (PTSD)
5.4.3. Sub-Type Specific cases of the Post-Traumatic Stress Disorder (PTSD) *
5.4.4. Sex- Specific Cases of the Post-Traumatic Stress Disorder (PTSD) *
5.4.5. Diagnosed Cases of the Post-Traumatic Stress Disorder (PTSD)
5.4.6. Treatable Cases of the Post-Traumatic Stress Disorder (PTSD)
5.5. France
5.5.1. Assumptions and Rationale
5.5.2. Prevalent/Incident Cases of the Post-Traumatic Stress Disorder (PTSD)
5.5.3. Sub-Type Specific cases of the Post-Traumatic Stress Disorder (PTSD) *
5.5.4. Sex- Specific Cases of the Post-Traumatic Stress Disorder (PTSD) *
5.5.5. Diagnosed Cases of the Post-Traumatic Stress Disorder (PTSD)
5.5.6. Treatable Cases of the Post-Traumatic Stress Disorder (PTSD)
5.6. Italy
5.6.1. Assumptions and Rationale
5.6.2. Prevalent/Incident Cases of the Post-Traumatic Stress Disorder (PTSD)
5.6.3. Sub-Type Specific cases of the Post-Traumatic Stress Disorder (PTSD) *
5.6.4. Sex- Specific Cases of the Post-Traumatic Stress Disorder (PTSD) *
5.6.5. Diagnosed Cases of the Post-Traumatic Stress Disorder (PTSD)
5.6.6. Treatable Cases of the Post-Traumatic Stress Disorder (PTSD)
5.7. Spain
5.7.1. Assumptions and Rationale
5.7.2. Prevalent/Incident Cases of the Post-Traumatic Stress Disorder (PTSD)
5.7.3. Sub-Type Specific cases of the Post-Traumatic Stress Disorder (PTSD) *
5.7.4. Sex- Specific Cases of the Post-Traumatic Stress Disorder (PTSD) *
5.7.5. Diagnosed Cases of the Post-Traumatic Stress Disorder (PTSD)
5.7.6. Treatable Cases of the Post-Traumatic Stress Disorder (PTSD)
5.8. United Kingdom
5.8.1. Assumptions and Rationale
5.8.2. Prevalent/Incident Cases of the Post-Traumatic Stress Disorder (PTSD)
5.8.3. Sub-Type Specific cases of the Post-Traumatic Stress Disorder (PTSD) *
5.8.4. Sex- Specific Cases of the Post-Traumatic Stress Disorder (PTSD) *
5.8.5. Diagnosed Cases of the Post-Traumatic Stress Disorder (PTSD)
5.8.6. Treatable Cases of the Post-Traumatic Stress Disorder (PTSD)
5.9. Japan
5.9.1. Assumptions and Rationale
5.9.2. Prevalent/Incident Cases of the Post-Traumatic Stress Disorder (PTSD)
5.9.3. Sub-Type Specific cases of the Post-Traumatic Stress Disorder (PTSD) *
5.9.4. Sex- Specific Cases of the Post-Traumatic Stress Disorder (PTSD) *
5.9.5. Diagnosed Cases of the Post-Traumatic Stress Disorder (PTSD)
5.9.6. Treatable Cases of the Post-Traumatic Stress Disorder (PTSD)
6. Current Treatment & Medical practices
6.1. Treatment Algorithm
6.2. Treatment Guidelines
7. Unmet Needs of the Post-Traumatic Stress Disorder (PTSD)
8. Marketed Therapies
8.1. Drug A: Company 1
8.1.1. Drug Description
8.1.2. Mechanism of Action
8.1.3. Regulatory Milestones
8.1.4. Advantages & Disadvantages
8.1.5. Product Profile
8.2. Drug B: Company 2
8.2.1. Drug Description
8.2.2. Mechanism of Action
8.2.3. Regulatory Milestones
8.2.4. Advantages & Disadvantages
8.2.5. Product Profile
9. Pipeline Therapies - At a glance
10. Key Cross Competition
11. Emerging Therapies for Post-Traumatic Stress Disorder (PTSD)
11.1. Drug C: Company 3
11.1.1. Drug Description
11.1.2. Clinical Trials Details
11.1.3. Safety and Efficacy Profile
11.1.4. Advantages & Disadvantages
11.1.5. Pipeline Development Activities
11.1.6. Product Profile
11.2. Drug D: Company 4
11.2.1. Drug Description
11.2.2. Clinical Trials Details
11.2.3. Safety and Efficacy Profile
11.2.4. Advantages & Disadvantages
11.2.5. Pipeline Development Activities
11.2.6. Product Profile
12. Post-Traumatic Stress Disorder (PTSD) : 7MM Market Analysis
12.1. 7MM Market Size of Post-Traumatic Stress Disorder (PTSD)
12.2. 7MM Percentage Share of drugs marketed for Post-Traumatic Stress Disorder (PTSD)
12.3. 7MM Market Sales of Post-Traumatic Stress Disorder (PTSD) by Products
13. Post-Traumatic Stress Disorder (PTSD) : Country-Wise Market Analysis
13.1. United States
13.1.1. Market Size of Post-Traumatic Stress Disorder (PTSD) in United States
13.1.2. Percentage Share of drugs marketed for Post-Traumatic Stress Disorder (PTSD) in United States
13.1.3. Market Sales of Post-Traumatic Stress Disorder (PTSD) by Products in United States
13.1.4. Analysis of Upcoming Therapies and their Impact on the Market
13.2. EU-5
13.2.1. Germany
13.2.1.1. Market Size of Post-Traumatic Stress Disorder (PTSD) in Germany
13.2.1.2. Percentage Share of drugs marketed for Post-Traumatic Stress Disorder (PTSD) in Germany
13.2.1.3. Market Sales of Post-Traumatic Stress Disorder (PTSD) by Products in Germany
13.2.1.4. Analysis of Upcoming Therapies and their Impact on the Market
13.2.2. France
13.2.2.1. Market Size of Post-Traumatic Stress Disorder (PTSD) in France
13.2.2.2. Percentage Share of drugs marketed for Post-Traumatic Stress Disorder (PTSD) in France
13.2.2.3. Market Sales of Post-Traumatic Stress Disorder (PTSD) by Products in France
13.2.2.4. Analysis of Upcoming Therapies and their Impact on the Market
13.2.3. Italy
13.2.3.1. Market Size of Post-Traumatic Stress Disorder (PTSD) in Italy
13.2.3.2. Percentage Share of drugs marketed for Post-Traumatic Stress Disorder (PTSD) in Italy
13.2.3.3. Market Sales of Post-Traumatic Stress Disorder (PTSD) by Products in Italy
13.2.3.4. Analysis of Upcoming Therapies and their Impact on the Market
13.2.4. Spain
13.2.4.1. Market Size of Post-Traumatic Stress Disorder (PTSD) in Spain
13.2.4.2. Percentage Share of drugs marketed for Post-Traumatic Stress Disorder (PTSD) in Spain
13.2.4.3. Market Sales of Post-Traumatic Stress Disorder (PTSD) by Products in Spain
13.2.4.4. Analysis of Upcoming Therapies and their Impact on the Market
13.2.5. United Kingdom
13.2.5.1. Market Size of Post-Traumatic Stress Disorder (PTSD) in United Kingdom
13.2.5.2. Percentage Share of drugs marketed for Post-Traumatic Stress Disorder (PTSD) in United Kingdom
13.2.5.3. Market Sales of Post-Traumatic Stress Disorder (PTSD) by Products in United Kingdom
13.2.5.4. Analysis of Upcoming Therapies and their Impact on the Market
13.3. Japan
13.3.1. Market Size of Post-Traumatic Stress Disorder (PTSD) in Japan
13.3.2. Percentage Share of drugs marketed for Post-Traumatic Stress Disorder (PTSD) in Japan
13.3.3. Market Sales of Post-Traumatic Stress Disorder (PTSD) by Products in Japan
13.3.4. Analysis of Upcoming Therapies and their Impact on the Market
14. Market Drivers
15. Market Barriers
16. Appendix
17. Report Methodology
17.1. Sources
18. DelveInsight Capabilities
19. Disclaimer
20. About DelveInsight
*Indication Specific

List of Tables

Table 1: Total Prevalent/Incident Cases of the Post-Traumatic Stress Disorder (PTSD) in 7MM
Table 2: Total Prevalent/Incident Cases of the Post-Traumatic Stress Disorder (PTSD) in 7MM by Countries
Table 3: Prevalent/Incident Cases of the Post-Traumatic Stress Disorder (PTSD) in United States (2016-2027)
Table 4: Sub-Type Specific cases of the Post-Traumatic Stress Disorder (PTSD) in United States (2016-2027)
Table 5: Sex- Specific Cases of the Post-Traumatic Stress Disorder (PTSD) in United States (2016-2027)
Table 6: Diagnosed Cases of the Post-Traumatic Stress Disorder (PTSD) in United States (2016-2027)
Table 7: Treatable Cases of the Post-Traumatic Stress Disorder (PTSD) in United States (2016-2027)
Table 8: Prevalent/Incident Cases of the Post-Traumatic Stress Disorder (PTSD) in Germany (2016-2027)
Table 9: Sub-Type Specific cases of the Post-Traumatic Stress Disorder (PTSD) in Germany (2016-2027)
Table 10: Sex- Specific Cases of the Post-Traumatic Stress Disorder (PTSD) in Germany (2016-2027)
Table 11: Diagnosed Cases of the Post-Traumatic Stress Disorder (PTSD) in Germany (2016-2027)
Table 12: Treatable Cases of the Post-Traumatic Stress Disorder (PTSD) in Germany (2016-2027)
Table 13: Prevalent/Incident Cases of the Post-Traumatic Stress Disorder (PTSD) in France (2016-2027)
Table 14: Sub-Type Specific cases of the Post-Traumatic Stress Disorder (PTSD) in France (2016-2027)
Table 15: Sex- Specific Cases of the Post-Traumatic Stress Disorder (PTSD) in France (2016-2027)
Table 16: Diagnosed Cases of the Post-Traumatic Stress Disorder (PTSD) in France (2016-2027)
Table 17: Treatable Cases of the Post-Traumatic Stress Disorder (PTSD) in France (2016-2027)
Table 18: Prevalent/Incident Cases of the Post-Traumatic Stress Disorder (PTSD) in Italy (2016-2027)
Table 19: Sub-Type Specific cases of the Post-Traumatic Stress Disorder (PTSD) in Italy (2016-2027)
Table 20: Sex- Specific Cases of the Post-Traumatic Stress Disorder (PTSD) in Italy (2016-2027)
Table 21: Diagnosed Cases of the Post-Traumatic Stress Disorder (PTSD) in Italy (2016-2027)
Table 22: Treatable Cases of the Post-Traumatic Stress Disorder (PTSD) in Italy (2016-2027)
Table 23: Prevalent/Incident Cases of the Post-Traumatic Stress Disorder (PTSD) in Spain (2016-2027)
Table 24: Sub-Type Specific cases of the Post-Traumatic Stress Disorder (PTSD) in Spain (2016-2027)
Table 25: Sex- Specific Cases of the Post-Traumatic Stress Disorder (PTSD) in Spain (2016-2027)
Table 26: Diagnosed Cases of the Post-Traumatic Stress Disorder (PTSD) in Spain (2016-2027)
Table 27: Treatable Cases of the Post-Traumatic Stress Disorder (PTSD) in Spain (2016-2027)
Table 28: Prevalent/Incident Cases of the Post-Traumatic Stress Disorder (PTSD) in UK (2016-2027)
Table 29: Sub-Type Specific cases of the Post-Traumatic Stress Disorder (PTSD) in UK (2016-2027)
Table 30: Sex- Specific Cases of the Post-Traumatic Stress Disorder (PTSD) in UK (2016-2027)
Table 31: Diagnosed Cases of the Post-Traumatic Stress Disorder (PTSD) in UK (2016-2027)
Table 32: Treatable Cases of the Post-Traumatic Stress Disorder (PTSD) in UK (2016-2027)
Table 33: Prevalent/Incident Cases of the Post-Traumatic Stress Disorder (PTSD) in Japan (2016-2027)
Table 34: Sub-Type Specific cases of the Post-Traumatic Stress Disorder (PTSD) in Japan (2016-2027)
Table 35: Sex- Specific Cases of the Post-Traumatic Stress Disorder (PTSD) in Japan (2016-2027)
Table 36: Diagnosed Cases of the Post-Traumatic Stress Disorder (PTSD) in Japan (2016-2027)
Table 37: Treatable Cases of the Post-Traumatic Stress Disorder (PTSD) in Japan (2016-2027)
Table 38: Marketed Therapies
Table 39: Emerging Therapies
Table 40: Key Cross Competition
Table 41:7MM- Market Size of Post-Traumatic Stress Disorder (PTSD) in USD MM (2016-2027)
Table 42:7MM- Market Share Post-Traumatic Stress Disorder (PTSD) by Therapies in USD MM (2016-2027)
Table 43:7MM- Market Sales of Post-Traumatic Stress Disorder (PTSD) by Therapies in USD MM (2016-2027)
Table 44: United States-Market Size of Post-Traumatic Stress Disorder (PTSD) in USD MM (2016-2027)
Table 45: United States-Market Share Post-Traumatic Stress Disorder (PTSD) by Therapies in USD MM (2016-2027)
Table 46: United States-Market Sales of Post-Traumatic Stress Disorder (PTSD) by Therapies in USD MM (2016-2027)
Table 47: Germany-Market Size of Post-Traumatic Stress Disorder (PTSD) in USD MM (2016-2027)
Table 48: Germany-Market Share Post-Traumatic Stress Disorder (PTSD) by Therapies in USD MM (2016-2027)
Table 49: Germany-Market Sales of Post-Traumatic Stress Disorder (PTSD) by Therapies in USD MM (2016-2027)
Table 50: France-Market Size of Post-Traumatic Stress Disorder (PTSD) in USD MM (2016-2027)
Table 51: France-Market Share Post-Traumatic Stress Disorder (PTSD) by Therapies in USD MM (2016-2027)
Table 52: France-Market Sales of Post-Traumatic Stress Disorder (PTSD) by Therapies in USD MM (2016-2027)
Table 53: Italy-Market Size of Post-Traumatic Stress Disorder (PTSD) in USD MM (2016-2027)
Table 54: Italy-Market Share Post-Traumatic Stress Disorder (PTSD) by Therapies in USD MM (2016-2027)
Table 55: Italy-Market Sales of Post-Traumatic Stress Disorder (PTSD) by Therapies in USD MM (2016-2027)
Table 56: Spain-Market Size of Post-Traumatic Stress Disorder (PTSD) in USD MM (2016-2027)
Table 57: Spain-Market Share Post-Traumatic Stress Disorder (PTSD) by Therapies in USD MM (2016-2027)
Table 58: Spain-Market Sales of Post-Traumatic Stress Disorder (PTSD) by Therapies in USD MM (2016-2027)
Table 59:UK-Market Size of Post-Traumatic Stress Disorder (PTSD) in USD MM (2016-2027)
Table 60:UK-Market Share Post-Traumatic Stress Disorder (PTSD) by Therapies in USD MM (2016-2027)
Table 61:UK-Market Sales of Post-Traumatic Stress Disorder (PTSD) by Therapies in USD MM (2016-2027)
Table 62: Japan-Market Size of Post-Traumatic Stress Disorder (PTSD) in USD MM (2016-2027)
Table 63: Japan-Market Share Post-Traumatic Stress Disorder (PTSD) by Therapies in USD MM (2016-2027)
Table 64: Japan-Market Sales of Post-Traumatic Stress Disorder (PTSD) by Therapies in USD MM (2016-2027)

List of Figures

Figure 1: Total Prevalent/Incident Cases of the Post-Traumatic Stress Disorder (PTSD) in 7MM
Figure 2: Total Prevalent/Incident Cases of the Post-Traumatic Stress Disorder (PTSD) in 7MM by Countries
Figure 3: Prevalent/Incident Cases of the Post-Traumatic Stress Disorder (PTSD) in United States (2016-2027)
Figure 4: Sub-Type Specific cases of the Post-Traumatic Stress Disorder (PTSD) in United States (2016-2027)
Figure 5: Sex- Specific Cases of the Post-Traumatic Stress Disorder (PTSD) in United States (2016-2027)
Figure 6: Diagnosed Cases of the Post-Traumatic Stress Disorder (PTSD) in United States (2016-2027)
Figure 7: Treatable Cases of the Post-Traumatic Stress Disorder (PTSD) in United States (2016-2027)
Figure 8: Prevalent/Incident Cases of the Post-Traumatic Stress Disorder (PTSD) in Germany (2016-2027)
Figure 9: Sub-Type Specific cases of the Post-Traumatic Stress Disorder (PTSD) in Germany (2016-2027)
Figure 10: Sex- Specific Cases of the Post-Traumatic Stress Disorder (PTSD) in Germany (2016-2027)
Figure 11: Diagnosed Cases of the Post-Traumatic Stress Disorder (PTSD) in Germany (2016-2027)
Figure 12: Treatable Cases of the Post-Traumatic Stress Disorder (PTSD) in Germany (2016-2027)
Figure 13: Prevalent/Incident Cases of the Post-Traumatic Stress Disorder (PTSD) in France (2016-2027)
Figure 14: Sub-Type Specific cases of the Post-Traumatic Stress Disorder (PTSD) in France (2016-2027)
Figure 15: Sex- Specific Cases of the Post-Traumatic Stress Disorder (PTSD) in France (2016-2027)
Figure 16: Diagnosed Cases of the Post-Traumatic Stress Disorder (PTSD) in France (2016-2027)
Figure 17: Treatable Cases of the Post-Traumatic Stress Disorder (PTSD) in France (2016-2027)
Figure 18: Prevalent/Incident Cases of the Post-Traumatic Stress Disorder (PTSD) in Italy (2016-2027)
Figure 19: Sub-Type Specific cases of the Post-Traumatic Stress Disorder (PTSD) in Italy (2016-2027)
Figure 20: Sex- Specific Cases of the Post-Traumatic Stress Disorder (PTSD) in Italy (2016-2027)
Figure 21: Diagnosed Cases of the Post-Traumatic Stress Disorder (PTSD) in Italy (2016-2027)
Figure 22: Treatable Cases of the Post-Traumatic Stress Disorder (PTSD) in Italy (2016-2027)
Figure 23: Prevalent/Incident Cases of the Post-Traumatic Stress Disorder (PTSD) in Spain (2016-2027)
Figure 24: Sub-Type Specific cases of the Post-Traumatic Stress Disorder (PTSD) in Spain (2016-2027)
Figure 25: Sex- Specific Cases of the Post-Traumatic Stress Disorder (PTSD) in Spain (2016-2027)
Figure 26: Diagnosed Cases of the Post-Traumatic Stress Disorder (PTSD) in Spain (2016-2027)
Figure 27: Treatable Cases of the Post-Traumatic Stress Disorder (PTSD) in Spain (2016-2027)
Figure 28: Prevalent/Incident Cases of the Post-Traumatic Stress Disorder (PTSD) in UK (2016-2027)
Figure 29: Sub-Type Specific cases of the Post-Traumatic Stress Disorder (PTSD) in UK (2016-2027)
Figure 30: Sex- Specific Cases of the Post-Traumatic Stress Disorder (PTSD) in UK (2016-2027)
Figure 31: Diagnosed Cases of the Post-Traumatic Stress Disorder (PTSD) in UK (2016-2027)
Figure 32: Treatable Cases of the Post-Traumatic Stress Disorder (PTSD) in UK (2016-2027)
Figure 33: Prevalent/Incident Cases of the Post-Traumatic Stress Disorder (PTSD) in Japan (2016-2027)
Figure 34: Sub-Type Specific cases of the Post-Traumatic Stress Disorder (PTSD) in Japan (2016-2027)
Figure 35: Sex- Specific Cases of the Post-Traumatic Stress Disorder (PTSD) in Japan (2016-2027)
Figure 36: Diagnosed Cases of the Post-Traumatic Stress Disorder (PTSD) in Japan (2016-2027)
Figure 37: Treatable Cases of the Post-Traumatic Stress Disorder (PTSD) in Japan (2016-2027)
Figure 38: Marketed Therapies
Figure 39: Emerging Therapies
Figure 40: Key Cross Competition
Figure 41:7MM- Market Size of Post-Traumatic Stress Disorder (PTSD) in USD MM (2016-2027)
Figure 42:7MM- Market Share Post-Traumatic Stress Disorder (PTSD) by Therapies in USD MM (2016-2027)
Figure 43:7MM- Market Sales of Post-Traumatic Stress Disorder (PTSD) by Therapies in USD MM (2016-2027)
Figure 44: United States-Market Size of Post-Traumatic Stress Disorder (PTSD) in USD MM (2016-2027)
Figure 45: United States-Market Share Post-Traumatic Stress Disorder (PTSD) by Therapies in USD MM (2016-2027)
Figure 46: United States-Market Sales of Post-Traumatic Stress Disorder (PTSD) by Therapies in USD MM (2016-2027)
Figure 47: Germany-Market Size of Post-Traumatic Stress Disorder (PTSD) in USD MM (2016-2027)
Figure 48: Germany-Market Share Post-Traumatic Stress Disorder (PTSD) by Therapies in USD MM (2016-2027)
Figure 49: Germany-Market Sales of Post-Traumatic Stress Disorder (PTSD) by Therapies in USD MM (2016-2027)
Figure 50: France-Market Size of Post-Traumatic Stress Disorder (PTSD) in USD MM (2016-2027)
Figure 51: France-Market Share Post-Traumatic Stress Disorder (PTSD) by Therapies in USD MM (2016-2027)
Figure 52: France-Market Sales of Post-Traumatic Stress Disorder (PTSD) by Therapies in USD MM (2016-2027)
Figure 53: Italy-Market Size of Post-Traumatic Stress Disorder (PTSD) in USD MM (2016-2027)
Figure 54: Italy-Market Share Post-Traumatic Stress Disorder (PTSD) by Therapies in USD MM (2016-2027)
Figure 55: Italy-Market Sales of Post-Traumatic Stress Disorder (PTSD) by Therapies in USD MM (2016-2027)
Figure 56: Spain-Market Size of Post-Traumatic Stress Disorder (PTSD) in USD MM (2016-2027)
Figure 57: Spain-Market Share Post-Traumatic Stress Disorder (PTSD) by Therapies in USD MM (2016-2027)
Figure 58: Spain-Market Sales of Post-Traumatic Stress Disorder (PTSD) by Therapies in USD MM (2016-2027)
Figure 59:UK-Market Size of Post-Traumatic Stress Disorder (PTSD) in USD MM (2016-2027)
Figure 60:UK-Market Share Post-Traumatic Stress Disorder (PTSD) by Therapies in USD MM (2016-2027)
Figure 61:UK-Market Sales of Post-Traumatic Stress Disorder (PTSD) by Therapies in USD MM (2016-2027)
Figure 62: Japan-Market Size of Post-Traumatic Stress Disorder (PTSD) in USD MM (2016-2027)
Figure 63: Japan-Market Share Post-Traumatic Stress Disorder (PTSD) by Therapies in USD MM (2016-2027)
Figure 64: Japan-Market Sales of Post-Traumatic Stress Disorder (PTSD) by Therapies in USD MM (2016-2027)
  • Global Epilepsy Therapeutic Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023
    Published: 12-Oct-2018        Price: US 3480 Onwards        Pages: 145
    Epilepsy is characterized by recurrent seizures caused by the improper balance between inhibitory and excitatory signals in the brain. The symptoms of epilepsy, caused by brain malformations and tumors, birth trauma, and high-risk pregnancies, can be benign or life-threatening. A majority of epilepsy cases have an unknown etiology. Scope of the Report: This report studies the Epilepsy Therapeutic market status and outlook of Global and major regions, from angles of players,......
  • 2018-2023 Global Epilepsy Therapeutics Market Report (Status and Outlook)
    Published: 11-Oct-2018        Price: US 6990 Onwards        Pages: 119
    In this report, LP Information studies the present scenario (with the base year being 2017) and the growth prospects of global Epilepsy Therapeutics market for 2018-2023. Epilepsy is a chronic neurological disorder that cause recurrent unprovoked seizures, characterized by brief and undetectable episodes of involuntary movement involving either a body part (partial) or the entire body (generalized). Neurological disorders treatment market is growing at a significant rate, d......
  • Global Neurodegenerative Diseases Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 02-Oct-2018        Price: US 3480 Onwards        Pages: 135
    Neurodegenerative diseases are becoming increasingly prevalent due to an aging population, but this diverse therapy area remains largely untreatable with current therapies. Neurodegenerative diseases are characterized by neuronal death within the brain and/or central nervous system (CNS), leading to progressive decline in functional neurological capacities. It has a devastating effect on quality of life and independence, often requiring full-time care during the later disease stages. ......
  • Global Traumatic Brain Injury Partnering 2012 to 2018
    Published: 01-Oct-2018        Price: US 1995 Onwards        Pages: 100
    "Delivery of this report will take 1-3 days after purchase." Provides comprehensive understanding and unprecedented access to the thaumatic brain injury partnering deals and agreements entered into by the worlds leading healthcare companies. The Global Traumatic Brain Injury Partnering Terms and Agreements since 2012 report provides understanding and access to partnering deals and agreements entered into by the world's leading healthcare companies. -......
  • Global Motor Neurone Disease Partnering 2012 to 2018
    Published: 01-Oct-2018        Price: US 1995 Onwards        Pages: 150
    "Delivery of this report will take 1-3 days after purchase." Provides understanding and access to the motor neurone disease partnering deals and agreements entered into by the worlds leading healthcare companies. The Global Motor Neurone Disease Partnering Terms and Agreements since 2012 report provides understanding and access to partnering deals and agreements entered into by the world's leading healthcare companies. - Trends in partnering deals......
  • Global Migraine Partnering 2012 to 2018
    Published: 01-Oct-2018        Price: US 1995 Onwards        Pages: 150
    "Delivery of this report will take 1-3 days after purchase." Provides understanding and access to the migraine partnering deals and agreements entered into by the worlds leading healthcare companies. The Global Migraine Partnering Terms and Agreements since 2012 report provides understanding and access to partnering deals and agreements entered into by the world's leading healthcare companies. - Trends in partnering deals - Top deals by value......
  • Global Epilepsy Partnering 2012 to 2018
    Published: 01-Oct-2018        Price: US 1995 Onwards        Pages: 150
    "Delivery of this report will take 1-3 days after purchase." Provides understanding and access to the epilepsy partnering deals and agreements entered into by the worlds leading healthcare companies. The Global Epilepsy Partnering Terms and Agreements since 2012 report provides understanding and access to partnering deals and agreements entered into by the world's leading healthcare companies. - Trends in partnering deals - Top deals by value......
  • Global Stroke Partnering 2012 to 2018
    Published: 01-Oct-2018        Price: US 1995 Onwards        Pages: 150
    "Delivery of this report will take 1-3 days after purchase." Provides understanding and access to the stroke partnering deals and agreements entered into by the worlds leading healthcare companies. The Global Stroke Partnering Terms and Agreements since 2012 report provides understanding and access to partnering deals and agreements entered into by the world's leading healthcare companies. - Trends in partnering deals - Top deals by value......
  • Global Neuralgia Partnering 2012-2018
    Published: 01-Oct-2018        Price: US 1995 Onwards        Pages: 150
    "Delivery of this report will take 1-3 days after purchase." Provides understanding and access to the neuralgia partnering deals and agreements entered into by the worlds leading healthcare companies. The Global Neuralgia Partnering Terms and Agreements since 2012 report provides understanding and access to partnering deals and agreements entered into by the world's leading healthcare companies. - Trends in partnering deals - Top deals by valu......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs